Mar 2019 $20 M No. 6 $10 to $50 million 10
Optiscan Biomedical Corp.: Raise no. 6, Mar 2019 × Investors in this round 10 investors had bought by the notice of Mar 26, 2019: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $25 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cary Vance · Executive Officer, Director Patrick Nugent · Executive Officer Aditya Puri · Director Charles Liamos · Director Kenneth Abramowitz · Director Paul Mieyal · Director Scott Halsted · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Patrick Nugent, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 26, 2019. Read the notice at the SEC .
equity SEC Jan 2018 $15 M No. 5 $10 to $50 million 10
Optiscan Biomedical Corp.: Raise no. 5, Jan 2018 × Investors in this round 10 investors had bought by the notice of Feb 14, 2018: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $20 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Donald Webber · Executive Officer Patrick Nugent · Executive Officer William Mince · Executive Officer, Director Aditya Puri · Director Charles Liamos · Director Kenneth Abramowitz · Director Paul Mieyal · Director Scott Halsted · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William Mince, Chief executive officer. Source: SEC Form D, newest notice filed Feb 14, 2018. Read the notice at the SEC .
equity SEC May 2016 $29 M No. 4 $10 to $50 million 16
Optiscan Biomedical Corp.: Raise no. 4, May 2016 × Investors in this round 16 investors had bought by the notice of Jun 7, 2016: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $29 M of $40 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Donald Webber · Executive Officer Jim Causey · Executive Officer Patrick Nugent · Executive Officer Peter Rule · Executive Officer, Director Aditya Puri · Director Charles Liamos · Director Kenneth Abramowitz · Director Paul Mieyal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Rule, Chief executive officer. Source: SEC Form D, newest notice filed Jun 7, 2016. Read the notice at the SEC .
equity SEC Jan 2013 $31 M No. 3 $10 to $50 million 16
Optiscan Biomedical Corp.: Raise no. 3, Jan 2013 × Investors in this round 16 investors had bought by the notice of Feb 7, 2013: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $46 M offered; $15 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Patrick Nugent · Executive Officer Peter Rule · Executive Officer, Director Charles Liamos · Director Paul Mieyal · Director Robin Bellas · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter Rule, President & CEO. Source: SEC Form D, newest notice filed Feb 7, 2013. Read the notice at the SEC .
equity SEC Oct 2012 $3 M No. 2 $2 to $10 million 2
Optiscan Biomedical Corp.: Raise no. 2, Oct 2012 × Investors in this round 2 investors had bought by the notice of Oct 29, 2012: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter Rule · Executive Officer, Director Charles Liamos · Director Paul Mieyal · Director Robin Bellas · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peter rule, President & CEO. Source: SEC Form D, newest notice filed Oct 29, 2012. Read the notice at the SEC .
options SEC Apr 2010 $32 M No. 1 $10 to $50 million 12
Optiscan Biomedical Corp.: Raise no. 1, Apr 2010 × Investors in this round 12 investors had bought by the notice of Apr 14, 2010: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $32 M of $38 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter Rule · Executive Officer, Director Charles Lianos · Director Julie Eskay-Eagle · Director Paul Mieyal · Director Ralph Christofferson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D, newest notice filed Apr 14, 2010. Read the notice at the SEC .
equity SEC